by Marq M. In July 2012, the U.S. Food & Drug Administration approved Truvada as Pre-Exposure Prophylaxis (PrEP). Simultaneously, there’s been increasing awareness around additional benefits of Highly Active Antiretroviral Therapy (HAART) as a method of preventing HIV transmission, as well as reinfection from other strains. That understanding caught on to an extent that, in […]